<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04192591</url>
  </required_header>
  <id_info>
    <org_study_id>A4082</org_study_id>
    <nct_id>NCT04192591</nct_id>
  </id_info>
  <brief_title>A 5-year Superion® IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)</brief_title>
  <official_title>A 5-year Superion® IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compile real-world outcomes of the Superion® IDS in routine clinical practice.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To compile real-world outcomes of the Superion® IDS in routine clinical practice, when used&#xD;
      according to the applicable Directions for Use&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 30, 2020</start_date>
  <completion_date type="Anticipated">January 2027</completion_date>
  <primary_completion_date type="Anticipated">January 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of success at the 24-month follow-up visit</measure>
    <time_frame>24-Months</time_frame>
    <description>Non-inferiority of overall subject success at the 24-Month visit vs. the 24-month visit in IDE trial. An individual subject will be considered a success if they meet all of the following conditions at the 24-month follow-up visit:&#xD;
Clinically significant improvement of neurogenic claudication symptoms as determined by meeting at least two of three domains of the ZCQ&#xD;
≥ 0.5-point improvement in physical function&#xD;
≥ 0.5-point improvement in symptom severity&#xD;
≤ 2.5 point on patient satisfaction domain&#xD;
No reoperations, removals, revisions, or supplemental fixation at the index level(s)&#xD;
No major implant or procedure-related complications&#xD;
no dislodgement, migration, or device deformation&#xD;
no new or persistent worsened neurological deficit at the index level†&#xD;
no unhealed spinous process fractures † Defined as a serious adverse event wherein there is any new/worsening of motor or sensory function at 12 months, compared to baseline, which persists to 24 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction: VertiFlex® Patient Satisfaction Survey</measure>
    <time_frame>24-, 36-, 48- and 60-Months</time_frame>
    <description>Proportion of subjects with VertiFlex® Patient Satisfaction Survey scoring ≥3 on a 4-point scale</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">214</enrollment>
  <condition>Lumbar Spinal Stenosis</condition>
  <arm_group>
    <arm_group_label>Superion® IDS device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Superion® Indirect Decompression System (IDS)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Superion® IDS device</intervention_name>
    <description>The Superion® IDS is a minimally-invasive spinal implant that treats LSS symptoms by limiting extension at the symptomatic level that compresses the neural elements and is designed for percutaneous surgical placement.</description>
    <arm_group_label>Superion® IDS device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:&#xD;
&#xD;
          -  45 years of age or older when written informed consent is obtained&#xD;
&#xD;
          -  Persistent leg/buttock/groin pain, with or without back pain that is consistently&#xD;
             relieved by flexion activities (example: sitting or bending over a shopping cart).&#xD;
&#xD;
          -  Diagnosis of degenerative spinal stenosis of the lumbar spine, defined as the&#xD;
             narrowing of the midline sagittal spinal canal (central) and/or narrowing between the&#xD;
             facet superior articulating process (SAP), the posterior vertebral margin (lateral&#xD;
             access), and the nerve root canal (foraminal).&#xD;
&#xD;
          -  Subject signed a valid, IRB-approved informed consent form (ICF) provided in English.&#xD;
&#xD;
          -  Subjects, who, in the opinion of the Clinical Investigator, are able to understand&#xD;
             this clinical investigation, cooperate with the investigational procedures and are&#xD;
             willing to return for all the required post-treatment follow-ups.&#xD;
&#xD;
          -  Able to independently read and complete all questionnaires and assessments provided in&#xD;
             English&#xD;
&#xD;
        Key Exclusion Criteria:&#xD;
&#xD;
          -  Axial back pain only.&#xD;
&#xD;
          -  Fixed motor deficit in lower extremity(ies) due to LSS.&#xD;
&#xD;
          -  Has any pain-related diagnosis, medical/psychological condition or external factors&#xD;
             that, in the investigator's medical judgment, might confound reporting of study&#xD;
             outcomes (e.g. history of pelvic pain, anginal pain, chronic migraine, involved in&#xD;
             litigation, workmen's compensation, spinal tumor)&#xD;
&#xD;
          -  Participating (or intends to participate) in another drug or device clinical trial&#xD;
             that may influence the data that will be collected for this study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roshini Jain</last_name>
    <role>Study Director</role>
    <affiliation>Boston Scientific Corporation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rebecca Apruzzese</last_name>
    <phone>323-326-8479</phone>
    <email>Rebecca.Apruzzese@bsci.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Diane Keesey</last_name>
    <phone>661-949-4175</phone>
    <email>diane.keesey@bsci.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Coastal Pain and Spinal Diagnostics</name>
      <address>
        <city>Carlsbad</city>
        <state>California</state>
        <zip>92009</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific Clinical Research</last_name>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vitamed Research</name>
      <address>
        <city>Rancho Mirage</city>
        <state>California</state>
        <zip>92270</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific Clinical Research Manager</last_name>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Holy Cross Hospital</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific Clinical Research Manager</last_name>
    </contact>
    <contact_backup>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Orthopaedic Institute</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific Clinical Research Manager</last_name>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Florida Pain Management</name>
      <address>
        <city>Sebastian</city>
        <state>Florida</state>
        <zip>32958</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific Clinical Research</last_name>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Alliance Spine and Pain Centers</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30326</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific Clinical Research R Manager</last_name>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centurion Spine and Pain</name>
      <address>
        <city>Waycross</city>
        <state>Georgia</state>
        <zip>31501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific Clinical Research</last_name>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Axis Spine Center</name>
      <address>
        <city>Coeur d'Alene</city>
        <state>Idaho</state>
        <zip>83815</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific Clinical Research Manager</last_name>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific Clinical Research</last_name>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Alexian Brothers Medical Center</name>
      <address>
        <city>Elk Grove Village</city>
        <state>Illinois</state>
        <zip>60007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific Clinical Research</last_name>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific Clinical Research</last_name>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Forest Health Medical Center</name>
      <address>
        <city>Ypsilanti</city>
        <state>Michigan</state>
        <zip>48198</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific Clinical Research Manager</last_name>
    </contact>
    <contact_backup>
      <phone>8552139890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Pacific Sports and Spine, LLC</name>
      <address>
        <city>Eugene</city>
        <state>Oregon</state>
        <zip>97401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific Clinical Research Manager</last_name>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Center for Interventional Pain and Spine</name>
      <address>
        <city>Lancaster</city>
        <state>Pennsylvania</state>
        <zip>17601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific Clinical Research Manager</last_name>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>SC Pain and Spine Specialists</name>
      <address>
        <city>Murrells Inlet</city>
        <state>South Carolina</state>
        <zip>29576</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific Clinical Research Manager</last_name>
    </contact>
    <contact_backup>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Central Texas Pain Institute</name>
      <address>
        <city>Killeen</city>
        <state>Texas</state>
        <zip>76542</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific Clinical Research Manager</last_name>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Precision Spine Care</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific Clinical Research Manager</last_name>
    </contact>
    <contact_backup>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Swedish Health Services</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific Clinical Research</last_name>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwest Pain Care</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific Clinical Research Manager</last_name>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Spine and Nerve Center of Saint Francis Hospital</name>
      <address>
        <city>Charleston</city>
        <state>West Virginia</state>
        <zip>25301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific Clinical Research Manager</last_name>
    </contact>
    <contact_backup>
      <phone>855-213-9890</phone>
      <email>BSNClinicalTrials@bsci.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.vertiflexstudy.com/</url>
    <description>The SCOPE Study for Spinal Stenosis (vertiflexstudy.com)</description>
  </link>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 6, 2019</study_first_submitted>
  <study_first_submitted_qc>December 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2019</study_first_posted>
  <last_update_submitted>October 12, 2021</last_update_submitted>
  <last_update_submitted_qc>October 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lumbar Spinal Stenosis</keyword>
  <keyword>LSS</keyword>
  <keyword>Chronic Pain</keyword>
  <keyword>Leg Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

